You have 9 free searches left this month | for more free features.

Membranous Nephropathy

Showing 1 - 25 of 1,042

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

T- and B-Cell Subpopulations in Membranous Nephropathy

Recruiting
  • Membranous Nephropathy
  • +2 more
    • Istanbul, Turkey
      Istanbul University
    May 31, 2023

    Idiopathic Membranous Nephropathy

    Not yet recruiting
    • Idiopathic Membranous Nephropathy
    • Obinutuzumab Injection
    • (no location specified)
    May 8, 2023

    Primary Membranous Nephropathy Trial (MIL62, Cyclosporine)

    Not yet recruiting
    • Primary Membranous Nephropathy
    • (no location specified)
    May 16, 2023

    Membranous Nephropathy Trial in Nice (Peginterferon Alfa-2A 180 MCG/ML Injectable Solution)

    Not yet recruiting
    • Membranous Nephropathy
    • Peginterferon Alfa-2A 180 MCG/ML Injectable Solution
    • Nice, France
      CHU de NICE
    Jul 4, 2023

    Nephropathy, Glomerular Diseases, Idiopathic Membranous Nephropathy Trial (Huaier granule, Renin-angiotensin-aldosterone system

    Not yet recruiting
    • Nephropathy
    • +2 more
    • Huaier granule
    • +2 more
    • (no location specified)
    Apr 20, 2023

    Idiopathic Membranous Nephropathy Trial in Beijing (Rituximab, Modified Ponticelli regimen)

    Recruiting
    • Idiopathic Membranous Nephropathy
    • Beijing, China
      Beijing Friendship Hospital, Capital Medical University
    Mar 23, 2023

    Membranous Nephropathy - PLA2R Induced Trial in Saint Petersburg (Rituximab, Cyclophosphamide, and Corticosteroids)

    Recruiting
    • Membranous Nephropathy - PLA2R Induced
    • Rituximab, Cyclophosphamide, and Corticosteroids
    • Saint Petersburg, Russian Federation
      St. Petersburg State Pavlov Medical University
    Jan 7, 2023

    Primary Membranous Nephropathy Trial (Zanubrutinib, Tacrolimus)

    Not yet recruiting
    • Primary Membranous Nephropathy
    • (no location specified)
    Jan 23, 2023

    Idiopathic Membranous Nephropathy Trial in Beijing

    Recruiting
    • Idiopathic Membranous Nephropathy
      • Beijing, Beijing, China
      • +2 more
      Jan 18, 2023

      PLA2R-IgG4 Detection Kit

      Enrolling by invitation
      • Membranous Nephropathy - PLA2R Induced
      • Kidney Diseases-except Membranous Nephropathy
        • Hangzhou, China
          ZhejiangBiostar
        May 6, 2023

        Primary Membranous Nephropathy Trial (SNP-ACTH (1-39) Gel, Rituximab)

        Not yet recruiting
        • Primary Membranous Nephropathy
        • (no location specified)
        Jan 13, 2023

        Membranous Nephropathy Trial in China (efgartigimod IV, )

        Recruiting
        • Membranous Nephropathy
        • efgartigimod IV
        • placebo
        • Changsha, China
        • +8 more
        Apr 11, 2023

        Primary Membranous Nephropathy Trial in Australia (Obinutuzumab, Oral prednisolone and cyclophosphamide)

        Not yet recruiting
        • Primary Membranous Nephropathy
        • Garran, Australian Capital Territory, Australia
        • +12 more
        Nov 1, 2023

        Autoreactive B Cells in Membranous Nephropathy

        Recruiting
        • Membranous Nephropathy
        • In vitro assays.
        • Ranica, BG, Italy
          Centro di Ricerche Cliniche per le Malattie Rare " Aldo e Cele D
        Nov 2, 2022

        Prognostic Model of Rituximab in the Treatment of MN

        Not yet recruiting
        • Idiopathic Membranous Nephropathy
        • (no location specified)
        Dec 28, 2022

        Prognostic Model of TAC in the Treatment of MN

        Not yet recruiting
        • Idiopathic Membranous Nephropathy
        • (no location specified)
        Dec 28, 2022

        Prognostic Model of GC/CTX in the Treatment of MN

        Not yet recruiting
        • Idiopathic Membranous Nephropathy
        • glucocorticoid + cytoxan
        • (no location specified)
        Dec 28, 2022

        Idiopathic Membranous Nephropathy Trial (glucocorticoid + tacrolimus)

        Not yet recruiting
        • Idiopathic Membranous Nephropathy
        • glucocorticoid + tacrolimus
        • (no location specified)
        Dec 28, 2022

        Primary Membranous Nephropathy Trial in Beijing (B007)

        Not yet recruiting
        • Primary Membranous Nephropathy
        • Beijing, China
          Peking university first hospital
        Dec 20, 2022

        Nephrotic Syndrome, Proteinuria, Autoimmune Disease Trial run by the NIDDK (Rituximab Infusion, Oral Cyclosporine)

        Recruiting
        • Nephrotic Syndrome
        • +4 more
        • Rituximab Infusion
        • Oral Cyclosporine
        • Bethesda, Maryland
        • +1 more
        Jan 25, 2023

        Idiopathic Membranous Nephropathy Trial (Rituximab, Cyclophosphamide)

        Not yet recruiting
        • Idiopathic Membranous Nephropathy
        • (no location specified)
        Aug 22, 2022

        Membranous Nephropathy Trial in New York (ACTHar)

        Completed
        • Membranous Nephropathy
        • New York, New York
          Icahn School of Medicine at Mount Sinai
        Jul 20, 2022

        Urinary Biomarker in Membranous Glomerulonephritis

        Not yet recruiting
        • Membranous Nephropathy
        • urinary markers
        • (no location specified)
        Jan 18, 2023

        Glomerulonephritis, Membranous, Nephrotic Syndrome,Idiopathic Trial in Japan (Rituximab (genetical recombination), Placebo)

        Not yet recruiting
        • Glomerulonephritis, Membranous
        • Nephrotic Syndrome,Idiopathic
        • Rituximab (genetical recombination)
        • Placebo
        • Anjo, Aichi, Japan
        • +7 more
        Jun 13, 2023

        Primary Membranous Nephropathy Trial (EVER001)

        Not yet recruiting
        • Primary Membranous Nephropathy
        • (no location specified)
        Mar 23, 2023